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Abstract
Pigment epithelium-derived factor (PEDF) is widely known for its neurotrophic and antiangiogenic functions. Efficacy
studies of PEDF in animal models are limited because of poor heterologous protein yields. Here, we redesigned the human
PEDF gene to preferentially match codon frequencies of E coli without altering the amino acid sequence. Following de novo
synthesis, codon optimized PEDF (coPEDF) and the wtPEDF genes were cloned into pET32a containing a 59 thioredoxin
sequence (Trx) and the recombinant Trx-coPEDF or Trx-wtPEDF fusion constructs expressed in native and two tRNA
augmented E coli hosts - BL21-CodonPlus(DE3)-RIL and BL21-CodonPlus(DE3)-RP, carrying extra copies of tRNA
arg,ile,leu and
tRNA
arg,pro genes , respectively. Trx-PEDF fusion proteins were isolated using Ni-NTA metal affinity chromatography and
PEDF purified after cleavage with factor Xa. Protein purity and identity were confirmed by western blot, MALDI-TOF, and
UV/CD spectral analyses. Expression of the synthetic gene was ,3.4 fold greater (212.7 mg/g; 62.1 mg/g wet cells) and
purified yields ,4 fold greater (41.1 mg/g; 11.3 mg/g wet cell) than wtPEDF in the native host. A small increase in
expression of both genes was observed in hosts supplemented with rare tRNA genes compared to the native host but
expression of coPEDF was ,3 fold greater than wtPEDF in both native and codon-bias-adjusted E coli strains. DGs at 23t o
+50 of the Trx site of both fusion genes were 23.9 kcal/mol. Functionally, coPEDF was equally as effective as wtPEDF in
reducing oxidative stress, promoting neurite outgrowth, and blocking endothelial tube formation. These findings suggest
that while rare tRNA augmentation and mRNA folding energies can significantly contribute to increased protein expression,
preferred codon usage, in this case, is advantageous to translational efficiency of biologically active PEDF in E coli. This
strategy will undoubtedly fast forward studies to validate therapeutic utility of PEDF in vivo.
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Introduction
Pigment epithelium-derived factor (PEDF) is a polypeptide
functionally characterized in the nervous system as a protein with
neuroprotective and antiangiogenic activities [1,2]. Its major
synthesis and secretion in the eye is by the retinal pigment
epithelium (RPE) [1]. In humans, PEDF is found in quantities of
144 nM in the interphotoreceptor matrix (IPM), 21 nM in the
vitreous humor and 6 nM in the aqueous humor of the eye [1] and
in approximately 8 to 24 mg/ml (mean (SD) 14.3 mg/ml) in serum
[3]. The PEDF gene encodes 418 amino acid residues and its
calculated molecular weight is 46 kDa [4]. PEDF contains a single
carbohydrate side chain that increases its apparent molecular
weight to 50 kDa on polyacrylamide gels.
The importance of this protein to biological systems has been
demonstrated in a many in vitro and in vivo models. Some of these
include studies which showed the neurotrophic and cell survival
actions of the protein on a wide range of neurons in the CNS as
well as the photoreceptor and retinal ganglion cells of the eye [1].
The PEDF gene is highly conserved in evolution and resides on
human chromosome 17p13 [5–7]. The neurotrophic activity of
PEDF is localized to the N terminal part of the protein,
corresponding to amino acid residues 78–121 [8]. The multifunc-
tional actions of the molecules is separated on distinct peptide
domains which appear to activate different receptors including the
laminin receptor [9], VEGF R1 [10], and the ATLG receptor
[11]. Its effectiveness as an angiogenesis inhibitor has been defined
by its ability to inhibit retinal endothelial cell (EC) growth and
migration and the abnormal growth of blood vessels in eyes
subjected to ischemic injury, hyperoxia, exitotoxicity and axotomy
[1,12,13]. The levels of PEDF decreases in many angiogenic and
neurodegenerative eye diseases, suggesting it is important to the
health and function of the eye [2,14,15]. Not only is it important to
ocular diseases, several studies have reported that tumor burden of
some cancers can be reduced by the antiangiogenic and
differentiation properties of PEDF [16–25]. The 50 kDa protein
has structural and sequence homology with members of the serpin
gene family of proteinase inhibitors and contains a reactive center
loop (RCL) that is characteristic of this family [4,26]. The crystal
structure of PEDF shows a unique asymmetric charge amino acid
distribution, an unusual concentration of positively charged amino
acid residues which might be of functional importance, and several
possible functional domains including two binding sites with
extracellular matrix molecules [1,26,27].
Although there is some information about the structure of this
protein and its functional activities, many studies are limited lack
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(E.coli). Large amounts of PEDF are required for functional studies
in vivo that pertains to tumor growth and metastasis, vascular
diseases, degenerations in the CNS and for structural analysis of
protein-ligand interactions. PEDF has also been identified as a
niche signal for neural stem cell self-renewal and can induce cone
photoreceptor markers in primary retinal neural aggregates [28–
30]. Here we used codon optimization strategies to improve the
expression of PEDF in E coli. Codon optimization, a genetic
technique used to achieve optimum expression of a foreign gene in
a host’s cell system is achieved by replacing existing codons of a
specie with a set of more suitable host codons [31–34]. Bacteria
and mammals prefer to use different codons [34] so many
mammalian genes such as PEDF are poorly expressed in bacteria.
Alternatively, heterologous expression can be improved by
supplying the host with extra copies of rare tRNA genes [35].
The results from our work suggest that codon optimization of
PEDF for bacterial expression increases the yield of the protein
above the expression yields of the non-optimized gene in both
native E. coli strains and those supplemented with rare tRNA
genes. coPEDF is as functionally active as wtPEDF in promoting
neurite outgrowth from SHSY5Y neuroblastoma cells, in
protecting these cells from hydrogen peroxide toxicity, and in
preventing endothelial tube formation.
Materials and Methods
All tissue culture reagents were obtained from Invitrogen –
Gibco (Gaithersburg, MD) and the human SHSY5Y neuroblas-
toma cells from ATCC (Mannassas, VA). The restriction enzymes
XhoI, KpnI, BstbI, HindIII and factor Xa protease were
purchased from New England BioLabs (Beverly, MA). The
BL21Star(DE3) and TOP10 chemically competent cells were
obtained from Invitrogen life technologies (Carlsbad, CA) and
BL21-CodonPlus(DE3)-RIL and BL21-CodonPlus(DE3)-RP com-
petent cells from Stratagene (La Jolla, CA). The pET32a vector
and Ni-NTA His-Bind resin was purchased from Novagen
(Madison, WI) and Goat anti rabbit conjugated IgG from Jackson
ImmunoResearch Laboratories (West Grove, PA). All PCR
primers were synthesized by the HMC Molecular Genetics Core
Facility at PSU.
Codon optimization of human PEDF cDNA for Expression
in E coli
The human full-length PEDF DNA (1257 bp) was codon-
optimized for bacterial expression using Genscript OptimumGen-
e
TM design platform, which employs a unique algorithm and
proprietary codon usage table. Modifications were made through-
out the sequence in approximately 25.5% of the DNA. Codon
optimized PEDF (coPEDF) was successfully assembled using
overlapping PCR (Genscript). The pCMV6-XL5 plasmid (Or-
igene, MD) containing the entire wild type PEDF (wtPEDF) DNA
was used to obtain the human wild type PEDF (wtPEDF) DNA
coding sequence of 1257 bp. The free energies of the genes (DG)
were computed using the online RNA folding program ‘‘mfold’’
(http://www.bioinfo.rpi.edu/applications/mfold [36].
Construction of Plasmids for Expression of coPEDF and
wtPEDF
The synthetic version of the gene (coPEDF) and wtPEDF DNA
containing the entire PEDF ORF with its synthetic and naturally
occurring amino terminus (Met
1-Pro
418) were cloned into the
pET32a vector (Novagen) using the KpnI and Hind III restriction
sites. The vector appends an N-terminal polyhistidine tag to the
protein for Ni-NTA metal-affinity chromatography purification,
an upstream protein folding enhancement thioredoxin (Trx)
fragment of 109 amino acids, and a cleavable Trx.Tag coding
sequence. The synthetic and wtPEDF plasmid constructs,
pET32a-coPEDF and pET32a-wtPEDF were used to transform
TOP10 chemically competent cells (invitrogen). Several trans-
formed colonies were isolated from ampicillin agar plates and
grown in 3 ml LB medium containing 100 ug/ml ampicillin.
coPEDF and wtPEDF plasmid DNAs were isolated from
minipreps and enzymatically digested with KpnI, XhoI and
BstBI, HindIII (Biolabs) respectively. The digested DNA were then
separated using 1% agarose gels and plasmids containing the DNA
product size (1257 bp) were subjected to sequencing (HMC
Molecular Genetics Core Facility at PSU).
Expression of coPEDF and wtPEDF
5 nanograms of pET32a-coPEDF and pET32a-wtPEDF
plasmid constructs were used to transform 50 ul E. coli
BL21Star(DE3) (invitrogen) for 30 min at 4uC, followed by 30 s
at 42uC. To correct heterologous expression problems that could
be caused by codon bias, the wtPEDF plasmid was also expressed
in BL21-CodonPlus(DE3) cells overexpressing rare tRNAs genes
for codons most frequently used in GC-rich mammalian genomes.
The coPEDF construct was also expressed in these cells to
determine whether codon usage alone increased heterologous gene
expression.
Plasmids were expressed in two BL21-CodonPlus(DE3) cells:
BL21CodonPlus(DE3)-RIL cells supplemented with extra copies
of the argU, ileY, and leuW tRNA genes (BL21-CodonPlus(DE3)-
RIL
argU, ileY, and leuW), which recognize AGA/AGG, AUA, and
CUA codons, respectively and in the BL21-CodonPlus(DE3)-RP
competent cells containing extra copies of the tRNA genes, argU
(BL21-CodonPlus(DE3)-RP
argU, proL) which recognizes the AGA
and AGG arginine codons, and proL which recognizes the proline
codon CCC (Stratagene).
The mixtures were incubated on ice for 2 min then, 250 ml
(SOC) medium added for an additional incubation at 37uC for
1 hr with constant shaking at 250 rpm. The cells were plated on
ampillicin agar plates and grown at 37uC overnight. Transformed
colonies of host cells containing the expression vectors were grown
in 1 liter LB medium containing 100 mg/ml ampicilin at 37uC
overnight to logarithmic phase. Initial expression of the proteins
was induced by 1 mmol/L isopropyl-b-D-triogalactoside (IPTG)
for 3 hr at 37u when the OD600 nm =0.8, 200 ml cells were
harvested by centrifugation and pellets resuspended in 25 ml
Laemmli Sample Buffer (Bio-Rad). Expressed proteins in the
subcellular fractions were detected by SDS-PAGE and western
blot analysis. Overexpressing clones from the synthetic and native
PEDF gene transformants were selected for optimizing induction
conditions, which included time of inducement, concentration of
IPTG, and inducement temperature.
For large-scale production, expression was carried out using
induction optimized conditions of 0.5 mmol/L IPTG for 5 hrs at
25uC. 1 L cultures of E-coli containing the constructs were grown
at 37uC in LB medium, 100 mg/ml ampicilin and expression
induced when the optical density of the cultures was approxi-
mately 0.8 units at OD600 nm. Cells were then harvested by
centrifugation at 4000 g for 20 min at 4uC. Bacterial yield was
approximately 2.28 g packed E. Coli cells/per L of culture. Cell
pellets were then lysed in buffer containing 10 mM sodium
phosphate, 150 mM sodium chloride, and 2% SDS pH 7.8 and
insoluble fractions removed by centrifugation at 12000 g for
30 min. The supernatant was collected and diluted in 50 mM
Codon Bias Influences PEDF Expression
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dialyzed against same buffer overnight at 4uC.
Protein purification
Soluble Trx-coPEDF and Trx-wtPEDF were isolated by Ni-
NTA metal-affinity chromatography. The dialysate was loaded
onto a Ni-NTA His-binding resin (Novagen) and column
equilibrated with 16Ni-NTA Binding Buffer containing 50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0. The flow
through was collected and the column washed with 16Ni-NTA
buffer containing 50 mM NaH2PO4, 300 mM NaCl, 20 mM
imidazole, pH 8.0. Bound His-tagged Trx-coPEDF and Trx-
wtPEDF were then eluted with 16 Ni-NTA buffer containing
50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0.
Protein fractions were pooled and concentrated using Amicon
Ultra Centrifugal Filter Device, with cellulose MWCO of 30 kDa
(Millipore, Billenica, MA). The protein fractions were then applied
onto Sephadex G-100 gel-filtration column (2.0650 cm) and
equilibrated with buffer containing 10 mM NaH2PO4, 150 mM
NaCl, pH 7.2, 3 mM DTT. Protein fractions were collected and
concentrated using an Eppendorf Speed Vac and protein
concentration determined using the Bradford assay (Bio-Rad)
and PEDF ELISA (Bioproducts, MD). Purity of the proteins was
estimated by 10% SDS-PAGE and the molecular weight con-
firmed by western blot analysis.
coPEDF and wtPEDF were cleaved from the 109 amino acid N-
terminal thioredoxin peptide at the Trx.Tag site IIeGluGlyArg
using factor Xa (BioLabs). The reaction proceeded ,6 hrs in
buffer containing 100 mM NaCl, 20 mM Tris-HCl, 2 mM CaCl2,
pH 8.0 at room temperature and factor Xa:protein with ratio
(unit/mg) of 1:50. The protein mixture was dialyzed against
50 mM NaPhosphate, 300 mM NaCl, pH 8.0 buffer and applied
twice sequentially onto Ni His-binding resin. The unbound
,50 kDa cleaved coPEDF and wtPEDF fractions were collected,
combined, concentrated, and dialyzed against PBS buffer
containing 10 mM NaPhosphate, 150 mM NaCl pH 7.8 using
Spectrapor dialysis membranes MWCO: 3 500 Da. The purified
protein was stored at 20uC. Protein purity and molecular weight
were confirmed by SDS-PAGE and western blot analyses. An
aliquot of the proteins were taken for mass spectrometry for
comparison and for UV and CD spectral analyses.
ELISA assay
coPEDF and wtPEDF concentrations in bacterial lysates and
after purification were estimated by ELISA assay (BioProducts
MD, Middletown, MD). Briefly, protein samples at 1:10 or 1:100
dilutions were incubated in human PEDF antibody coated 96well
plates for 1 h at 37uC. After several washes, a PEDF detector
antibody was added and incubated for an additional hour at 37uC
followed by washing and incubation with streptavidin-conjugated
peroxidase for 30 min at 37uC. This reagent was removed, wells
washed, and tetramethylbenzidine added as substrate. Optical
density was measured using a microplate reader (680XR, Bio-Rad,
Hercules, and CA) at wavelength 450 nm. The PEDF concentra-
tions (ng/ml) in each sample were estimated using internal PEDF
standards.
Western Blot analysis
The molecular weight of coPEDF was confirmed by western
blot analysis using the conditions of Laemli. 100 ng proteins was
resolved by SDS-PAGE and electro transferred to nitrocellulose
membrane (Bio-Rad) for 2 h at 0.3A. Membranes were washed
with 0.1% Tween-TBS (TBS-T) buffer (36, 10 min each) then
treated with TBS-T buffer containing 5% dry milk for 2 h at room
temperature and subsequently incubated with an anti PEDF
polyclonal antibody (1:1000; made in our lab) overnight at 4uC.
Blots were then incubated with goat anti rabbit conjugated IgG
(1:1000) (Bio-Rad) for 1 h at room temperature and antibody
binding visualized using the Imun-Star HRP Substrate Kit (Bio-
Rad) followed by exposure to BIOMAX MR FILM (Kodak).
Mass Spectrometry
coPEDF and wtPEDF were analyzed by mass spectrometry
(HMC Molecular Genetics Core Facility at PSU) to confirm
protein identity. Approximately 100 nM (10 ml) of the protein was
reduced with 20 ml of 2 mM TCEP (Tris(2-carboxyethyl)pho-
sphine, Sigma #C4706) in 25 mM ammonium bicarbonate
(NH4HCO3) (pH 8.0) at 37uC for 15 min. This was followed by
alkylation with 20 ml of 20 mM iodoacetamide in 25 mM
NH4HCO3. The solution was then incubated in the dark at
37uC for 30 min and dried. Samples were trypsinized with 27 mlo f
0.02 mg/ml of Promega Sequencing grade modified trypsin
(Promega, Madison, WI) in 10% acetonitrile, 40 mM NH4HCO3,
pH 8.0 overnight at 48uC and then evaporated to dryness.
Bicarbonate was removed from the sample by resuspension in
200 ml water and evaporated to dryness. This was repeated three
times followed by a final resuspension in 250 ml water and
evaporation to ,10 ml volume. 1 ml of 1% trifluoroacetic acid
solution in water was added, peptides desalted, concentrated using
ZipTip SCX tips (Millipore, Billerica, MA), and eluted directly
onto stainless still target plates (Applied Biosystems, Framingham,
MA). The sample spots were dried and overlaid with 0.7 ml of the
MALDI matrix, a-cyano-4-hydroxycinnamic acid, (Sigma) (5 mg/
ml in 50% acetonitrile, 2 mg/ml NH4HPO4) and then air-dried at
room temperature. The peptide mixtures were analyzed by mass
spectrometry using an Applied Biosystems (ABI) 4800 Proteomics
MALDI TOF/TOF Analyzer (Foster City, CA). Protein identi-
fication was carried out using the Mascot algorithm version 1.9
(Matrix Science, London, UK) as implemented in the GPS
Explorer analysis program (version 3.5, Applied Biosystems)
against nonredundant protein database and Swissport (version
2005.0315). Peptide mass fingerprints and MS/MS spectra with a
confidence interval of .95% were used as protein identification
criteria [37].
UV and circular dichroism (CD) spectroscopy
CD measurements of coPEDF and wtPEDF were performed
with a JASCO J-75 spectropolarimeter (Jasco, Easton, MD) and
the far UV CD spectra were obtained in the range of 210–260 nm
at 10uC. The temperature was controlled using a water bath
thermostat RTE-111 (Neslab, Instruments, Portsmount, NH).
Each spectrum was the result of the average of three individual
scans after subtraction of the buffer spectra. The protein
concentrations used for each sample was 0.2 20.4 mg/ml in
20 mM NaH2PO4, 1 mm DTT, pH 7.5 buffer. A path length of
1 mm barrel quartz cell was used in all experiments. The proteins
molar ellipticity was calculated as [D]=(D0*Mw/A)/10*L*C,
where D0, is the experimental ellipticity; Mw, the molecular mass
of protein; A, the number of amino acid residues, C, the protein
concentration in the solution in milligrams per milliliter; and L, the
optical path length in centimeters. UV spectrum was taken using a
U-2001 Spectrophotometer (Hitachi) and a 1cm rectangular
quartz cuvette.
Neurotrophic assays Neurite outgrowth. Human
neuroblastoma SHSY5Y cells (ATCC, Mannassas, VA) were
used to examine the neurite outgrowth effects of coPEDF as has
been reported for wtPEDF [1]. The cells were routinely
maintained in DMEM supplemented with 2% fetal bovine
Codon Bias Influences PEDF Expression
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streptomycinneomycin (PSN; Invitrogen, Carlsbad, CA). For the
neurite outgrowth experiments, SHSY5Y were seeded onto glass
coverslips in 24-well culture plates at a density of 1610
4 cells per
well. The cells were adapted to SF-MEM for 1 h, then treated
with wtPEDF (100 ng/ml) or coPEDF (100 ng/ml) in SF-MEM
for 5 d. Control cells were maintained in SF-MEM alone. Neurite
outgrowths were visualized in live cultures by light microscopy.
Samples were also fixed using 4% paraformaldehyde for 1 h at
room temperature and incubated with PBS containing 5% BSA
(PBS/BSA). The samples were then immunolabeled with
polyclonal rabbit anti-neurofilament 200 kDa (1:1000; Sigma, St
Louis, MO) overnight at 4uC, followed by incubation with goat
anti-rabbit cy3 (1:1000; Jackson ImmunoResearch, West Grove,
PA), FITC-conjugated phalloidin (1:1000; Invitrogen) and
Hoescht 33258 (1:10,000; Sigma) for 1 h at room temperature
and immunolabel visualized by confocal microscopy (Fluoview
FV1000 confocal microscope, Olympus, Center Valley, PA). Six
microscopic fields for each treatment were imaged and the neurite
length of 20 cells in each field measured using the Image J software
(NIH). The histogram shows the average neurite length of 3
independent experiments (mean 6 standard deviation (S.D.).
Oxidative stress assay. The protective effects of coPEDF
and wtPEDF against hydrogen peroxide (H2O2) toxicity were
determined in cultured neuroblastoma SHSY5Y exposed to
oxidative stress using the lactate dehydrogenase (LDH)
cytotoxicity assay (Roche, Indianapolis, IN, USA). Cells were
seeded in 96-well culture plates at a density of 1610
4 cells per well,
adapted to serum-free MEM (SF-MEM) for 1 h, then treated with
PEDF (100 ng/ml) or coPEDF (100 ng/ml) in SF-MEM for
24 hr. Control cultures were maintained in SF-MEM alone. The
cultures were then challenged with H2O2 (160 or 320 mM) for
24 h. In some experiments, the cultures were first treated with
600 mMH 2O2 for 1 hr after which time the H202 was removed
and the cultures treated with wtPEDF or coPEDF for 24 hr. The
percentage of cell death was estimated by measuring the LDH
activity in the RPE conditioned media.
Endothelial Tube formation assay. 24-well plates were
pre-coated with Matrigel (BD Biosciences), and HUVEC cells
(16105 cells/well) were seeded onto coated plates in the presence
of VEGF (3 ng/ml). The cultures were supplemented with one of
the following: wtPEDF (100 ng/ml), coPEDF (100 ng/ml), or the
non-antiangiogenic peptide PEDF78–121 (25 ng/ml) to determine
effects of these molecules on endothelial tube formation. After
Figure 1. Sequence comparison between wt and coPEDF genes. wt: wild-type; co: codon-optimized; aa: amino acid.
doi:10.1371/journal.pone.0015056.g001
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cultures and images taken using a phase contrast microscope (106)
with an attached CCD camera.
Results Cloning of artificially synthesized PEDF with
bacteria preferred codons
The efficiency of heterologous PEDF production in bacteria can
be greatly diminished by codon bias usage. Here we optimized
expression of the human wtPEDF gene using bacteria preferred
codons according to the GeneOptimizer software algorithm
(GeneScript, CA) for expression in the pET32a vector and
presented the comparative sequence in Figure 1. In the engineered
human PEDF gene there were replacements of several rare codons
to thosefavoredbybacteriafor example,CUCtoCUG(L), CCCto
CCG(P),AAGtoAAA(K), AGGtoCGC(R). Thereisalsoa better
balance in the frequency of usage for several codons between the
host and coPEDF, for example GUU (V), CAU (H), CCG (P), AAT
(N),GAA(E),CGU(R),UGU(C),GCA(A)(Figure2).Theincrease
in coPEDF expression most likely reflects these changes.
The base composition and GC% content of native and synthetic
PEDF cDNA sequences differ by 9.97% and 4.99%, respectively
(Figure 3) but there were no changes in the amino acid sequence
between the two proteins. Codon optimized PEDF was success-
fully assembled using overlapping PCR strategy and the wtPEDF
and coPEDF genes cloned into the pET32a vector with an
appended thioredoxin gene fragment of 109 amino acid sequence
to improve protein folding, 6 His-tag residues for ease of
purification of the expressed protein, and a factor Xa Trx.tag
sequence for easy cleavage of the 50 kDa PEDF protein (Figure 4).
PCR gel confirmed the expected product insert size of 1257 bp for
both wtPEDF and coPEDF and a high molecular weight band of
5900 bp representing the pET32a vector (Figure 5A). After
transformation of E. coli BL21Star (DE3) with the constructs,
several positive bacterial colonies were identified and two clones
(clone #3 for Trx-wtPEDF and clone #2 for TrxcoPEDF) were
selected for further analysis because of high expression yields
(Figure 5B). The proteins are shown to migrate at a molecular
weight of 65 kDa since they include the upstream 15 kDa
thioredoxin sequence (Figure 5B).
Figure 2. Comparison of codon usage in E coli, wtPEDF, coPEDF. The figure shows the codon changes made in synthetic PEDF (examples are
in bold type and underlined) and the frequency balance adjustments of codon usage between the host and coPEDF (examples are in bold type).
doi:10.1371/journal.pone.0015056.g002
Figure 3. Base composition and GC% content of wtPEDF and coPEDF.
doi:10.1371/journal.pone.0015056.g003
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Expression of the recombinant proteins in BL21Star(DE3) was
maximally induced with 0.5 mmol/L IPTG at 25uC for 5 hrs as
shown in the time course study in Figure 5C. The two constructs
were also expressed in the BL21-CodonPlus(DE3)-RIL
cells expressing the rare tRNA
argU,ileY,leuW genes, which recognize
the AGA/AGG, AUA, and CUA codons, respectively and the
BL21-CodonPlus(DE3)-RP cells expressing extra copies of the
tRNA
argU,proL genes, which recognizes the AGA/AGG and CCC
codons, respectively (Figure 5D,E). At all time points, there was
improved protein expression of the synthetic PEDF gene in native
and codon-bias adjusted host cells compared to the native gene in
bacterial lysates (Figure 5C,D,E). Using ELISA and densitometry
methods, the yields for Trx-wtPEDF and TrxcoPEDF in all host
Figure 4. pET32a constructs for wtPEDF and coPEDF protein expression in E.coli. The figure shows wtPEDF and coPEDF inserts, upstream
thioredoxin (Trx) fragment, factor Xa cleavage site, and mRNA folding energy of 3.9 kcal/mol at the Trx start site (23t o+50) of the fusion proteins.
doi:10.1371/journal.pone.0015056.g004
Figure 5. Expression of Trx-PEDF in bacteria. A. PCR gel showing the expected product insert size of 1257 bp for both wtPEDF and coPEDF and
the pET32a vector size. B. Comassie blue stained (CB) SDS gels showing lysates from BL21Star(DE3) colonies expressing the Trx-wtPEDF or Trx-coPEDF
fusion proteins at 65 kDa. Clone #3 and #2 were selected for high expression yields of the proteins. C.D.E. SDS gels showing expression levels of Trx-
wtPEDF and Trx-coPEDF fusion proteins with IPTG induction over 1–5 hr in BL21Star(DE3), and two codon-bias-adjusted host cells: BL21-
CodonPlus(DE3)-PR and BL21-CodonPlus(DE3)-RIL cells.
doi:10.1371/journal.pone.0015056.g005
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Table 1. While there was an insignificant increase in both Trx-
wtPEDF (,9% and 15%) and and Trx-coPEDF (1% and 5%) in
hosts supplied with extra copies of rare tRNA genes, the ratio of
expression was 3 to 3.4 fold greater yield of the codon-optimized
gene to the wt gene product in both conventional and codon-bias-
adjusted hosts (Table 1). Quantitative yields for the proteins in
BL21Star(DE3) host cell lysates between 1–5 hr expression are
presented in Figure 6 and table 2. At all comparable time points, the
yields of Trx-coPEDF were greater than those for the wt gene. The
highest expression levels were observed after 5 hr IPTG induction,
where the amount of Trx-coPEDF was 485 mg/L (212.7 mg
PEDF/g wet E coli) and Trx-wtPEDF, 142 mg/L (62.1 mg PEDF/
gw e tE. coli), representing an approximate 46greater yield of the
gene product with codon optimization (Table 2). No significant
growth differences in the bacterial cultures were observed at OD
600 nm after transfection of the plasmids.
Characterization of expressed coPEDF
Purification of the proteins by Ni-NTA metal-affinity chroma-
tography followed by cleavage from the N-terminal thioredoxin
withfactorXaresultedintheexpected 50 kDasize forwtPEDFand
coPEDF as shown in the comassie blue stained gel in Figure 7A
(Lane 1: uncleaved protein; lane 2: cleaved protein). The molecular
sizes of the proteins were confirmed by western blot analyses using a
PEDF polyclonal antibody generated in our lab as shown in
Figure 7B (Lanes1, 2: uncleaved and cleaved proteins respectively).
We obtained 94.1 mg/L (41.27 mg/g wet cells) purified
coPEDF (50 kDa) and 26.5 mg/L (11.62 mg/g wet cells) wtPEDF
(50 kDa) by expressing the pET32a constructs in BL21Star(DE3)
(Table 3). In comparison, the purified yields of native PEDF
expressed in pEV-BH [38], PET41a [39], pET22b [40], and yeast
Pichia Pastoris [41] were 2.6, 3.8, 10, and 20 mg/L (Tables 3, 4),
respectively, representing a 36 -5 fold increase in coPEDF
expression yields. There with also a ,10, 7, 3 fold increase of
wtPEDF using the pET32a vector compared to wtPEDF yields
using pEV-BH, pET41a, and pET22b, respectively and a 1.3 fold
increase over the yeast expression system (Tables 3, 4).
The coPEDF and wtPEDF proteins identity was confirmed by
gene sequencing and Maldi-TOF analyses (Figure 8) and by
circular dichroism (CD) spectroscopy (Figure 9), which monitors
global changes in the protein secondary structure [42]. Far UV
and CD spectra recordings indicated that bacteria preferred codon
usage did not alter the secondary structure of coPEDF and that the
molecules are a/b proteins.
RNA folding energies
Using the ‘‘mfold’’ RNA folding program, we calculated the free
energy of 59 translated Trx-coPEDF and Trx-wtPEDF mRNA at
(23t o+50) of the Trx start site. The calculations indicate that the
59 regions of both native and engineered fusion genes were
identical and contained mRNA structures with a DGo f
23.9 kcal/mol. This excludes the mRNA folding energy hypoth-
esis for increased translational yields of Trx-coPEDF.
coPEDF retains full biological activity as wtPEDF
Native PEDF is a potent neurotrophic and neuroprotective
agent [1]. Here we show that both wt and coPEDF proteins
induced neurite outgrowth from SHSY5Y neuroblastoma cells
(Figure 10A). The neurite lengths were 5.960.63 and 6.660.74-
fold longer when cells were cultured with either coPEDF
or wtPEDF, respectively, compared to non-treated controls
(Figure 10B). The neurites exhibited well-branched structures
and expressed the neurofilament 200 kDa protein as detected by
immunolabelling. This finding supports previous data that PEDF
promotes neurite outgrowths in neuroblastoma cells, another
neural derived tumor. wtPEDF and coPEDF were equally effective
in protecting the neuroblastoma cells from hydrogen peroxide
toxicity with a maximal 30% reduction in cell death when cells
were exposed to 200 mM H2O2 (Figure 10C). We also showed
Table 1. Quantitative yields of fusion proteins in bacteria
lysates after 5 h expression using densitometry and ELISA
assays.









BL21Star(DE3) 142 485 79.33 242.5
BL21-Codonplus(DE3)-RP 154 507 76.24 266.84
BL21-Codonplus(DE3)-RIL 163 488 80.30 256.84
A small increase in expression of both proteins was observed in hosts
supplemented with extra copies of rare tRNA genes but in all cases, coPEDF
expression was approximately 3–3.5 fold greater than wtPEDF.
doi:10.1371/journal.pone.0015056.t001
Figure 6. Time course expression yields for Trx-wtPEDF and
Trx-coPEDF fusion proteins in BL21Star(DE3) lysate.
doi:10.1371/journal.pone.0015056.g006
Table 2. Comparative yields of Trx-wtPEDF and Trx-coPEDF in
BL21Star(DE3) lysates.
mg/L mg/g wet cells
hr Trx-wtPEDF Trx-coPEDF Trx-wtPEDF Trx-coPEDF
1 77 103 33.6 45.2
2 95 212 41.5 93.0
3 132 363 57.9 159.2
4 141 428 61.7 187.7
5 142 485 62.1 212.7
Codon preference modifications of the PEDF gene resulted in greater
translational efficiency of the fusion proteins.
doi:10.1371/journal.pone.0015056.t002
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formation (63% inhibition compared to control; n=3) as the
native protein (Figure 11), which is not surprising since the amino
acid sequences of wt and coPEDF proteins are identical (Figure 1).
In this experiment we also showed that the neurotrophic PEDF
peptide (PEDF78–121), which served as a negative control in this
study, had negligible effects on endothelial tube formation. These
data provide evidence that codon bias improves yield of
biologically active PEDF and is a useful strategy for large-scale
production of this molecule for further biochemical and functional
analyses of the protein and for translational research.
Discussion
An alternative method for obtaining high yields of PEDF has
been an unmet need in the field of PEDF neuroregenerative
medicine. The objective of this work was to improve expression of
PEDF in E coli to obtain cost effective production of the protein for
translational research.
Heterologous production of recombinant mammalian proteins
can be quite challenging since these genes often contain expression
limiting regulatory elements and codons infrequently used outside
their original context [31,34,43]. The degeneracy of the genetic
code allows many amino acids to be encoded for by more than one
synonymous codon and the same protein by many alternative
nucleic acid sequences. The frequency with which a given codon is
used in the genetic code can vary significantly among organisms
but how an organism develops preferences for specific codons is a
vigorously disputed topic in molecular evolution. There is
consensus though, that codon preference correlate with cognate
isoacceptor tRNA concentrations available in the natural host
environment and reflects a balance necessary for efficiency of
translation. [31,34,43–45].
While E. coli is still the most widely used host for expressing
mammalian genes, codon usage space maps indicate that it is not
Figure 7. Purification of PEDF. A. Comassie blue (CB) stained SDS gels showing: lane 1: purified Trx-PEDF fusion protein (65 kDa); lane 2: cleaved
PEDF (50 kDa). B. Western Blots (WB) using a PEDF polyclonal antibody confirms PEDF protein identity in both the fusion and cleaved products. Lane
1: Purified Trx-PEDF fusion proteins (65 kDa); lane 2: cleaved PEDF (50 kDa).
doi:10.1371/journal.pone.0015056.g007
Table 3. Purified protein.
mg/L mg/g wet cells
wtPEDF(pET32a) 26.5 11.62
coPEDF(pET32a) 94.1 41.27
Quantitative measurement indicates a ,4 fold greater yield of purified cleaved
coPEDF protein over the native PEDF.
doi:10.1371/journal.pone.0015056.t003








2.6 (1.3 mg/g wet cells) [38] 3.8 [39] 10 [40] 20 [41]
The comparisons indicate an ,5–36 fold greater yield of the coPEDF protein in
all host expression systems tested over wtPEDF [38]. Becerra et.al., JBC 1993,
268:23148 [39]. Zhang et.al., Biotechnol Lett 2005, 27:403 [40]. Wang et.al., Prep
Biochem Biotechnol. 2006, 36:127 [41]. Sanchez et.al., J of Biotechnol 2008,
134:193.
doi:10.1371/journal.pone.0015056.t004
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codon usage because of the significant divergent codon bias that
exists between the two organisms [34]. In heterologous protein
expression, ribosomes pause when encountering a rare codon and
can detach from the mRNA and abort translation. Forced
expression of rare codon-containing genes is likely to exhaust
endogenous pools of the analogous tRNAs, and lead to growth
arrest, premature termination of transcription and/or translation,
decrease mRNA stability, and increased frameshifts, deletions, and
misincorporations. Heterologous expression then, may not only
result in reduced protein yields but lead to a mixture of expressed
proteins with altered function and increased immunogenicity, a
major consideration in translational research [34,46–49].
Although resolving codon bias is challenging, many have shown
that heterologous protein expression can be improved by
engineering foreign genes to preferentially use codons compatible
with the host without altering the protein or by supplying extra
copies of rare tRNA genes to host cells [50–54]. Both approaches
have shown success in dramatically improving heterologous
protein expression [34,49,55–59]. In some cases though, rare
codon substitutions with more favorable host codons can result in
protein misfolding, loss of biological function, and have a
significant impact on protein expression [49,60–63].
Here, we used both strategies and showed that expression of the
human PEDF protein is greatly improved by engineering the
native gene to be compatible with E coli codon bias usage.
Figure 8. MALDI-TOF analysis confirms that the wtPEDF and coPEDF proteins are identical.
doi:10.1371/journal.pone.0015056.g008
Figure 9. Structural identity comparisons by UV and CD spectral analyses. The profiles show that coPEDF and wtPEDF have similar UV and
CD spectra.
doi:10.1371/journal.pone.0015056.g009
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effect on expression of both native and synthetic PEDF genes.
Protein yields were more robust with the redesigned gene in both
conventional and codon bias-adjusted hosts compared to native
PEDF suggesting that optimizing the gene for bacterial codon
usage improved speed and efficiency of translation in this host.
Some have posited that translational efficiency is influenced by
the stability of the mRNA folding near the ribosomal binding site
of the protein and that codon bias has a net positive effect on the
overall fitness of host cells [64] while others argue that both are
important to translational efficiency [65]. In this case, however,
the native and synthetic PEDF mRNA folding energies were
identical and unlikely to contribute significantly to the differences
in translation efficiency observed. Both genes were expressed as
fusion proteins with the 109 amino acid upstream thioredoxin
gene and their DGs were 23.9 kcal/mol at the Trx translational
start site.
Native PEDF yields were greater by ,3 to 10 times more over
previously reported yields in bacterial hosts and expression levels
were similar in yeast [38–41]. The translational advantage of
wtPEDF in our expression system is most likely due to differences
in the vector used and an appended Trx sequence, which is known
to improve protein folding and translational efficiency [66]. We
did not observe a significant difference in expression of human
Trx-PEDF between codon-bias-adjusted hosts and conventional E.
coli hosts when the cells were transformed with the pET32a
wtPEDF or coPEDF constructs.
Regardless of the comparably higher yields of native PEDF to
other published expression systems, the synthetic codon optimized
gene resulted in protein levels that were ,5 to 36 fold greater than
amounts reported for the native gene [38–41] and a ,3 fold
greater yield in both codon-bias-adjusted and conventional E. coli
host cells transformed with the pET32a constructs. One might
argue that increasing host intracellular tRNA diversity increases
the metabolic load of actively growing organisms in a way that has
a negative impact on expression of a few proteins and/or that
specific bacterial proteins may repress the expression of some rare
tRNA genes [67]. The increase in coPEDF over wt PEDF
Figure 10. coPEDF promotes neurite outgrowth in SHSY5Y neuroblastoma cells and protects cells from hydrogen peroxide toxicity.
A. Cells treated with wtPEDF or coPEDF for 5 d were fixed and immunolabeled with antibodies against neurofilaments (red) and b-actin (green)
proteins, and stained with DAPI, (blue). B. The histogram represents the mean neurite length (+/2 SD). C. Neuroprotective effects were observed for
wtPEDF and coPEDF proteins when cells were treated with H2O2 for 24 hr. The LDH assay histogram shows that maximal effects were achieved with
100 ng/ml of either wt or coPEDF proteins when cells were exposed to 200 nM H2O2 (n=3).
doi:10.1371/journal.pone.0015056.g010
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replacement of specific codons in the gene with those favored by
the host and by balancing the frequency with which some codons
are used between the two systems. Addition of rare tRNA genes to
host cells did not boost wtPEDF levels, suggesting that, in this case,
a wider range of rare tRNA genes may be necessary to achieve the
levels obtained for the synthetic gene. While expanding the tRNA
diversity may be a good strategy to increase translational
efficiency, fidelity and function of the protein may be compro-
mised. As expected, there was no significant augmentation in
coPEDF expression in the codon-bias-adjusted host cells. One
possible explanation for this is that the extra tRNA genes
expressed in these cells recognized codons that were replaced in
the synthetic gene. Our findings suggest that while protein yields
can be influenced by choice of expression vectors, 59 mRNA
folding energies, or by increasing tRNA diversity in host cells,
redesigning some mammalian genes to use preferred host codons
may increase translational efficiency.
Not only was the codon bias adjusted gene expressed at higher
levels, the function of the protein remained intact, an important
consideration in clinical applications. Using both biophysical and
biochemical methods, we confirmed that the synthetic and wild
type gene products expressed in native E. coli competent cells were
identical and by functional assays validated the neurotrophic and
antiangiogenic efficacies of the proteins. An important finding
from this study is that the differentiation actions of PEDF on
tumor cells is not restricted to retinoblastoma [1] but may be a
general biological function of the protein on actively proliferating
neural tumors. It is tempting to speculate that the neurite
promoting activity of the protein on neural tumor cells is a
consequence of its actions in reducing oxidative stress. We also
showed that the antiangiogenic potency of the engineered gene
product is intact and comparable to the native protein in
endothelial tube formation assays. These findings have implica-
tions for the use of coPEDF in attenuating neural tumor growth
and metastasis by blocking angiogenesis and promoting tumor cell
differentiation and in neuroregenerative medicine where axonal
growth and neurite survival/regeneration are essential to restore
function.
In summary, heterologous PEDF expression is greatly improved
by using codons that match those preferred by the host
translational system without altering protein function. Large-scale
production of this protein is certainly an attractive approach to
facilitate the speed at which therapeutic efficacy can be validated
in larger animal models of tumor growth, angiogenesis, and
neurodegenerations without the drawbacks of viral mediated
transfer of the gene.
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